Search for: "RANBAXY INC" Results 1 - 20 of 142
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2024, 7:16 am by Zak Gowen
  Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India’s Ranbaxy Laboratories to delay sales of less expensive, generic versions of the cholesterol drug Lipitor. [read post]
24 May 2021, 7:34 am by Deb Givens
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
31 Jul 2020, 4:00 pm by Pete Strom
Pharmaceutical Manufacturer that Makes Generic Lipitor Will Pay Millions for Dangerous Drugs A subsidiary of India’s largest pharmaceutical company, Ranbaxy USA Inc, has agreed to pay the United States federal government a record $500 million in criminal and civil fines for selling adulterated drugs, including the generic version of Lipitor, and lying to regulators during the year-long investigation. [read post]
25 Jan 2019, 12:08 pm by Katherine Kiziah
MDL No. 2879 – In Re: Marriott International, Inc., Customer Data Security Breach Litigation. [read post]
25 Jan 2019, 12:08 pm by Katherine Kiziah
MDL No. 2879 – In Re: Marriott International, Inc., Customer Data Security Breach Litigation. [read post]
22 May 2015, 10:38 am
Unusually, a trial took place limited to the issue of infringement and in July 2011, Kitchin J (as he then was) held that Ranbaxy's product did not infringe. [read post]
1 Apr 2014, 9:50 pm by Zachary Ewing
Earlier in 2013, generic-drug-maker Ranbaxy agreed to pay $500 million in fines and settlement costs after the company pled guilty to federal drug safety violations. [read post]
20 Mar 2014, 3:49 pm
Jurors in a state court have awarded Kamie Kendall Rees $1,587,928 in her Accutane injury lawsuit against drug maker Hoffman La Roche Inc. [read post]
24 Feb 2014, 10:38 pm by Ben Vernia
Omnicare, Inc., a qui tam case brought in Maryland by a former employee of the long-term care pharmacy company, Omnicare. [read post]